2-(2-(4-(2-(4-(1-(2-ETHOXYETHYL)-1H- BENZO[D]IMIDAZOL-2-YL)PIPERIDIN-1- YL)ETHYL)PHENYL)PROPAN-2-YL)-4,4-DIMETHYL-4,5- DIHYDROOXAZOLE (N-1 INTERMEDIATE)(CAS: 202189-77-3)

Bilastine Impurity 12 (CAS: 202189-77-3) is a byproduct of the synthesis of the antihistamine drug bilastine. It is a white crystalline powder with a molecular weight of approximately 418.5 g/mol and a melting point of about 185-187°C. This impurity is characterized by its low toxicity and minimal pharmacological activity.

Bilastine Impurity 12 (CAS: 202189-77-3) is primarily used in quality control and analytical testing to monitor the purity of bilastine during manufacturing processes. It is also utilized in research settings to study the properties of the impurities present in pharmaceuticals.

Bilastine Impurity 12 (CAS: 202189-77-3) is considered relatively safe with minimal toxicity. However, as with any chemical, it should be handled with care. Users should avoid inhalation, ingestion, or skin contact and wear appropriate personal protective equipment (PPE) during handling and disposal.

Bilastine Impurity 12 (CAS: 202189-77-3) should be stored in a cool, dry, and well-ventilated place away from direct sunlight and heat sources. It should be kept in a tightly sealed container to prevent degradation. The storage temperature should be below 25°C to ensure its stability.